ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,489, issued on Oct. 14, was assigned to INTRA-CELLULAR THERAPIES INC. (Bedminster, N.J.).
"Organic compounds" was invented by Wei Yao (New Milford, N.J.), Peng Li (New Milford, N.J.), Robert Davis (San Diego), Sharon Mates (New York), Kimberly Vanover (New York) and Gretchen Snyder (New York).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to particular substituted heterocycle fused gamma-carbolines, their prodrugs, in free, solid, pharmaceutically acceptable salt and/or substantially pure form as described herein, pharmaceutical compositions thereof, and methods of use in the treatment of diseases involving the 5-HT2A receptor, ...